NEW YORK, June 21, 2017 /PRNewswire/ --
If you want a stock review on PRGO, LPNT, SEM, or UHS then come over to http://dailystocktracker.com/register/ and sign up for your free customized reports today. The Healthcare sector includes health care providers and services, health care equipment and supplies, and health care technology companies. It also includes companies involved in the research, development, production, and marketing of pharmaceuticals and biotechnology products. This morning, DailyStockTracker.com puts focus on Perrigo Co. PLC (NYSE: PRGO), LifePoint Health Inc. (NASDAQ: LPNT), Select Medical Holdings Corp. (NYSE: SEM), and Universal Health Services Inc. (NYSE: UHS). These free stocks reports are currently available on DailyStockTracker.com. Simply sign up for your complimentary member access at:
Dublin, Ireland headquartered Perrigo Co. PLC's stock finished Tuesday's session 1.07% lower at $72.36 with a total trading volume of 1.22 million shares. Over the last month and the previous three months, the Company's shares have advanced 2.22% and 6.19%, respectively. The stock is trading above its 50-day moving average by 1.18%. Moreover, shares of Perrigo, which together with its subsidiaries, develops, manufactures, markets, and distributes over-the-counter consumer goods and pharmaceutical products worldwide, have a Relative Strength Index (RSI) of 53.95.
On June 16th, 2017, research firm Cantor Fitzgerald initiated an 'Overweight' rating on the Company's stock, with a target price of $85 per share.
On June 19th, 2017, Perrigo announced that it has launched hydrocodone bitartrate and homatropine methylbromide oral solution. Hydrocodone bitartrate and homatropine methylbromide oral solution was formerly marketed under the trade name Hycodan® by Endo Pharmaceuticals Inc. It is indicated for the symptomatic relief of cough in adults and children six years of age and older. Annual market sales for the 12 months ending April 2017 were approximately $15 million. Your complete research report on PRGO can be retrieved for free at:
Shares in Brentwood, Tennessee-based LifePoint Health Inc. declined 1.22%, ending yesterday's session at $64.60 with a total trading volume of 217,699 shares. The stock has gained 4.28% in the past month, 7.67% in the previous three months, and 13.73% on an YTD basis. The Company's shares are trading 3.26% above their 50-day moving average and 6.96% above their 200-day moving average. Moreover, shares of LifePoint Health, which through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers, and post-acute facilities in the US, have an RSI of 59.77.
On June 07th, 2017, research firm Leerink Partners upgraded the Company's stock rating from 'Market Perform' to 'Outperform'.
On June 13th, 2017, LifePoint Health announced that its management will participate in the Goldman Sachs Leveraged Finance Conference on June 21st, 2017, in Rancho Palos Verdes, California. A replay of the presentation will be available for 30 days on the Company's website. A free report on LPNT is just a click away at:
On Tuesday, Mechanicsburg, Pennsylvania headquartered Select Medical Holdings Corp.'s stock closed the day flat at $14.15. A total volume of 1.08 million shares was traded, which was above their three months average volume of 642,810 shares. The Company's shares have advanced 1.43% in the last one month, 15.98% in the previous three months, and 6.79% on an YTD basis. The stock is trading 2.44% and 6.55% above its 50-day and 200-day moving averages, respectively. Additionally, shares of Select Medical, which through its subsidiary, Select Medical Corporation, operates specialty hospitals, outpatient rehabilitation clinics, and occupational medicine centers in the US, have an RSI of 53.62. Sign up for your complimentary research report on SEM at:
Universal Health Services
Shares in King of Prussia, Pennsylvania headquartered Universal Health Services Inc. ended the day 1.20% lower at $114.13. A total volume of 576,008 shares was traded. The stock has gained 7.29% since the start of this year. The Company's shares are trading below their 50-day moving average by 4.04%. Furthermore, shares of Universal Health Services, which through its subsidiaries, owns and operates acute care hospitals, behavioral health facilities, and ambulatory centers, have an RSI of 43.41.
On June 07th, 2017, research firm Morgan Stanley initiated an 'Equal-Weight' rating on the Company's stock. A free report on UHS is just a click away at:
Daily Stock Tracker:
Daily Stock Tracker (DST) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. DST has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
DST has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email email@example.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by DST. DST is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
DST, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. DST, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, DST, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither DST nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit
For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Phone number: (207)331-3313
Office Address: 377 Rivonia Boulevard, Rivonia, South Africa
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Chelmsford Park SA